Covariation MS uncovers a protein that controls cysteine catabolism.
Saved in:
| Title: | Covariation MS uncovers a protein that controls cysteine catabolism. |
|---|---|
| Authors: | Xiao H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. hpxiao@stanford.edu.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. hpxiao@stanford.edu.; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA. hpxiao@stanford.edu.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. hpxiao@stanford.edu., Ordonez M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Fink EC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Covington TA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Woldemichael HB; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Chen J; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Jain MS; Department of Computer Science, Stanford University, Stanford, CA, USA.; Harvard Medical School, Boston, MA, USA., Rohatgi MH; Department of Computer Science, Stanford University, Stanford, CA, USA., Wei SM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Burger N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Sharif MA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Jan J; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wang Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Petrocelli JJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Blackmore K; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Smythers AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Zhang B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Gilbert M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Cheong H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Khetarpal SA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Smith A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Bogoslavski D; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Lei Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Vaites LP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., McAllister FE; Calico Life Sciences, South San Francisco, CA, USA., Van Bruggen N; Calico Life Sciences, South San Francisco, CA, USA., Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Huttlin EL; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Mills EL; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Chouchani ET; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. edwardt_chouchani@dfci.harvard.edu.; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. edwardt_chouchani@dfci.harvard.edu.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. edwardt_chouchani@dfci.harvard.edu. |
| Source: | Nature [Nature] 2025 Nov; Vol. 647 (8088), pp. 268-276. Date of Electronic Publication: 2025 Sep 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
